Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Briacell Therapeutics Corp (BCTX)

Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BriaCell Adds NYU Langone Health’s Perlmutter Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study GlobeNewswire - Thu May 7, 6:30AM CDT

PHILADELPHIA and VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology...

BCT.TO : 5.73 (+2.32%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.0899 (-1.43%)
BCTXL : 1.0900 (+10.10%)
BCTX : 4.19 (+2.20%)
BriaCell Receives FDA Clearance to Initiate Bria-BRES+™ Clinical Study in Breast Cancer GlobeNewswire - Wed May 6, 6:30AM CDT

FDA clearance of Investigational New Drug (IND) application opens path to commence Phase 1/2a clinical study for Bria-BRES+ in metastatic breast cancer Bria-BRES+ is BriaCell’s next generation personalized...

BCT.TO : 5.73 (+2.32%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.0899 (-1.43%)
BCTXL : 1.0900 (+10.10%)
BCTX : 4.19 (+2.20%)
BriaCell Announces Six Clinical Data Presentations at ASCO 2026 GlobeNewswire - Mon Apr 27, 6:30AM CDT

Final randomized Phase 2 Bria-IMT™ survival and quality of life data to be presented Biomarker analyses from the ongoing Phase 3 study evaluating predictors of response PHILADELPHIA and...

BCT.TO : 5.73 (+2.32%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.0899 (-1.43%)
BCTXL : 1.0900 (+10.10%)
BCTX : 4.19 (+2.20%)
BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models GlobeNewswire - Tue Apr 21, 6:30AM CDT

Bria-OTS+ platform provides early, potent and durable activation of innate and adaptive immunity in in-vitro cancer cell line models Immune cells activated by Bria-OTS+ exhibit serial killing activity...

BCT.TO : 5.73 (+2.32%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.0899 (-1.43%)
BCTXL : 1.0900 (+10.10%)
BCTX : 4.19 (+2.20%)
BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting GlobeNewswire - Mon Apr 20, 6:30AM CDT

Phase 3 clinical data in heavily pretreated metastatic breast cancer patients with prior failed ADC, CPI, and CDK4/6 inhibitor treatments shows quality of life (QOL) largely preserved Identification...

BCT.TO : 5.73 (+2.32%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.0899 (-1.43%)
BCTXL : 1.0900 (+10.10%)
BCTX : 4.19 (+2.20%)
BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License GlobeNewswire - Tue Mar 31, 3:05PM CDT

PHILADELPHIA and VANCOUVER, British Columbia, March 31, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, BCTXL) (TSX: BCT) (“ BriaCell ”), a clinical-stage biotechnology...

BCT.TO : 5.73 (+2.32%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.0899 (-1.43%)
BCTXL : 1.0900 (+10.10%)
BCTX : 4.19 (+2.20%)
BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference GlobeNewswire - Wed Mar 18, 6:30AM CDT

PHILADELPHIA and VANCOUVER, British Columbia, March 18, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...

BCT.TO : 5.73 (+2.32%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.0899 (-1.43%)
BCTXL : 1.0900 (+10.10%)
BCTX : 4.19 (+2.20%)
BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting GlobeNewswire - Tue Mar 10, 6:30AM CDT

PHILADELPHIA and VANCOUVER, British Columbia, March 10, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology...

BCT.TO : 5.73 (+2.32%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.0899 (-1.43%)
BCTXL : 1.0900 (+10.10%)
BCTX : 4.19 (+2.20%)
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting GlobeNewswire - Thu Mar 5, 3:04PM CST

PHILADELPHIA and VANCOUVER, British Columbia, March 05, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX , BCTXL ) (TSX:BCT) (“BriaCell” or the “Company”) , a clinical-stage...

BCT.TO : 5.73 (+2.32%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.0899 (-1.43%)
BCTXL : 1.0900 (+10.10%)
BCTX : 4.19 (+2.20%)
BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License GlobeNewswire - Wed Feb 18, 4:30PM CST

PHILADELPHIA and VANCOUVER, British Columbia, Feb. 18, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, BCTXL) (TSX: BCT) (“ BriaCell ”), a clinical-stage biotechnology...

BCT.TO : 5.73 (+2.32%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.0899 (-1.43%)
BCTXL : 1.0900 (+10.10%)
BCTX : 4.19 (+2.20%)

Barchart Exclusives

JPMorgan vs. Bank of America: How the 2 Dividend-Paying Bank Stocks Stack Up in 2026 Barchart - Fri May 8, 6:00PM CDT
JPMorgan dominates on scale and profits, while Bank of America wins on value and yield. Here's which big bank stock deserves your money in 2026. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.